From variants to mechanisms: Neurogenomics in the post-GWAS era
Neuron · 2025
DOI: 10.1016/j.neuron.2025.10.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuron, 2025. Verfasst von Michael P Margolis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Biobehavioral Sciences, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Ang…. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Genomics, Mental Disorders, Genetic Variation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIMH NIH HHS, German Research Foundation.
Abstract (Originalsprache)
Genome-wide association studies (GWASs) have identified thousands of variants associated with neuropsychiatric disorders (NPDs), including autism spectrum disorder (ASD), schizophrenia (SCZ), and Alzheimer's disease (AD). However, deciphering the "causal" biological mechanisms and pathways through which these variants act remains a major obstacle that hinders translational understanding of NPD pathogenesis. NPDs are highly polygenic with contributions from pleiotropic variants across the allelic spectrum, most of which reside within large haplotype blocks in non-coding regions of the genome. Successful mechanistic insight requires identifying disease-relevant cell types and states, mapping variant-to-gene effects, and integrating findings across loci, at scale, to pinpoint pathways of polygenic convergence. Here, we discuss functional genomic, machine learning, and experimental approaches to address each step of this daunting challenge. Ultimately, the convergence of results-across methodologies and within key underlying disease pathways-will be essential to realizing the promise of clinical translation for common, complex brain disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry and Biobehavioral Sciences, Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024, USA; Department of Human Genetics, David Geffen School…
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, US…
- Department of Psychiatry, University of Münster, 48149 Münster, Germany; Lab for Genomics of Complex Diseases, Max Planck Institute of Psychiatry, 80804 Munich, Germany.
- University of Oxford Department of Psychiatry, Oxford OX3 7JX, UK; The University of Queensland Institute for Molecular Bioscience, Brisbane, QLD 4072, Australia.
- Department of Psychiatry, University of Münster, 48149 Münster, Germany; Center for Soft Nanoscience, University of Münster, 48149 Münster, Germany; Lab for Genomics of Complex Diseases, Max Planck Institute of Psychiat…
Förderung
- NIGMS NIH HHS
- NIMH NIH HHS
- German Research Foundation
- National Institute of Mental Health
- National Institute of General Medical Sciences
- Federal Ministry of Education and Research Bonn Office
- Simons Foundation Autism Research Initiative
Zitieren
APA
Margolis, M. P., Tang, M., Gagliardi, M., Wen, C., Wu, Y., Wray, N. R., Ziller, M. J., & Gandal, M. J. (2025). From variants to mechanisms: Neurogenomics in the post-GWAS era. Neuron. https://doi.org/10.1016/j.neuron.2025.10.014
Vancouver
Margolis MP, Tang M, Gagliardi M, Wen C, Wu Y, Wray NR, et al. From variants to mechanisms: Neurogenomics in the post-GWAS era. Neuron. 2025. doi:10.1016/j.neuron.2025.10.014
BibTeX
@article{Margolis2025,
author = {Margolis, Michael P and Tang, Miao and Gagliardi, Miriam and Wen, Cindy and Wu, Yeda and Wray, Naomi R and Ziller, Michael J and Gandal, Michael J},
title = {From variants to mechanisms: Neurogenomics in the post-GWAS era},
journal = {Neuron},
year = {2025},
doi = {10.1016/j.neuron.2025.10.014}
}
EUVIMED